B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus A/Darwin/9/2021 San-010 (H3N2), Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated

• Immunogenicity of licensed MF59 adjuvanted Influenza and SARS-CoV-2 vaccine combinations for Older Adults (ISOLDA) Ended
  2024-514798-23-00 Phase II 2 countries Cr2o B.V.
• Optimizing the time of day of influenza vaccine administration in adults aged 60-85 years: A randomized controlled trial Ended
  2024-513558-30-00 Phase IV 1 country Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Showing 1–2 of 2 trials